Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.43 USD | -1.75% | +1.44% | +110.75% |
15/03 | XBiotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
04/01 | XBiotech Inc. to Begin Constructing New R&D Facility on Its 48-Acre Campus | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+110.75% | 26Cr | |
+9.42% | 11TCr | |
+11.84% | 11TCr | |
-1.05% | 2.2TCr | |
-14.15% | 2.19TCr | |
-5.29% | 1.92TCr | |
-4.16% | 1.81TCr | |
-38.29% | 1.77TCr | |
+7.99% | 1.43TCr | |
+36.24% | 1.24TCr |
- Stock Market
- Equities
- XBIT Stock
- News XBiotech Inc.
- XBiotech Gets FDA Approval for Phase 2 Study of Potential Treatment for Rheumatoid Arthritis